Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.
Novel low-cost method for Cefmetazole Sodium via FeCl3 deprotection. High purity 92%, scalable route for antibiotic manufacturing.
Patent CN112759566B details a safer, high-yield (>96%) synthesis of ABL using liquid sodium methoxide, offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Analyzing patent CN105294657B for Crizotinib production. Offers high purity, scalable routes, and supply chain stability for pharmaceutical manufacturing partners.
Novel synthesis of 2-(2-amino-5-bromo-benzoyl) pyridine via Suzuki coupling offers safer, scalable production for Remimazolam intermediates, reducing operational risks.
Novel modular route for trityl candesartan intermediate avoiding complex protection groups. Enhances supply chain stability and reduces manufacturing costs for API production.
Patent CN110054577A discloses urea thiourea compounds targeting Ras mutations. This report analyzes synthesis scalability and supply chain advantages for pharmaceutical procurement.
Patent CN113185485A reveals a novel thiourea dioxide reduction method for dihydroquercetin, offering significant cost reduction and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.
Patent CN103980249A details high purity alogliptin benzoate refining. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical procurement teams.
Discover efficient synthesis of multi-substituted fused benzofuran derivatives. Patent CN106749139A offers simplified routes for pharmaceutical and electronic chemical manufacturing.
Explore the patented Grignard-based synthesis of Doxylamine Succinate (CAS 562-10-7). A scalable, high-purity route for pharmaceutical manufacturing and cost reduction.
Patent CN116622672A reveals high-efficiency carboxylesterase mutants for chiral acid production, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN113861222A reveals a novel bimetallic catalyst for desoxytazobactam synthesis, offering higher yields and safer processing for API manufacturers.
Novel chiral preparation of bis-trifluoromethyl spiro oxindoles offers high yield and stereoselectivity for reliable pharmaceutical intermediates supplier scalability.
Advanced patent-based synthesis of Cefepime Hydrochloride using quaternary ammonium intermediates and phase transfer catalysis for superior purity and yield.
Novel double dearomatization method for spiro-indolizidines. High yield up to 95%. Cost-effective route for API intermediates without precious metals.
Novel quaternary ammonium salt intermediate method enhances yield and purity for cefepime manufacturing, offering cost-effective supply chain solutions.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.
Novel 1,3-dipole cycloaddition synthesis for antitumor intermediates. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.